SURGERY PARTNERS INC (SGRY) — insider trading
Health Care · NASDAQ
SURGERY PARTNERS INC (SGRY) has 14 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases and 4 open-market sales among the most recent 14 (latest 2026-08-18).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | DeLuca Teresa | Director | Open-market purchase | 11,250 | $14.33 | $161.2K | Form 4/A |
| 2026-08-18 | DeLuca Teresa | Director | Open-market purchase | 10,000 | $14.35 | $143.5K | Form 4 |
| 2026-06-18 | HENDRIX BLAIR E | Director | Grant / award / vesting | 34,364 | $14.55 | $500.0K | Form 4 |
| 2026-06-05 | TURNER BRENT | Director | Grant / award / vesting | 11,670 | $13.71 | $160.0K | Form 4 |
| 2026-06-05 | DeLuca Teresa | Director | Grant / award / vesting | 11,670 | $13.71 | $160.0K | Form 4 |
| 2026-06-05 | Dean Lloyd H | Director | Grant / award / vesting | 11,670 | $13.71 | $160.0K | Form 4 |
| 2026-06-05 | ADLERZ CLIFFORD G | Director | Grant / award / vesting | 11,670 | $13.71 | $160.0K | Form 4 |
| 2026-06-05 | Forese Laura L | Director | Grant / award / vesting | 11,670 | $13.71 | $160.0K | Form 4 |
| 2026-06-05 | Deane John A | Director | Grant / award / vesting | 11,670 | $13.71 | $160.0K | Form 4 |
| 2026-06-05 | HENDRIX BLAIR E | Director, 10% owner | Grant / award / vesting | 11,670 | $13.71 | $160.0K | Form 4 |
| 2026-03-16 | Evans Jason Eric | Officer (Chief Executive Officer) | Open-market sale | 20,400 | $12.47 | $254.4K | Form 4 |
| 2026-03-16 | Doherty David T | Officer (Chief Financial Officer) | Open-market sale | 8,867 | $12.50 | $110.8K | Form 4 |
| 2026-03-13 | Brittenham Marissa | Officer (Chief Strategy Officer) | Open-market sale | 3,657 | $12.54 | $45.9K | Form 4 |
| 2026-03-13 | Burkhalter Danielle | Officer (Chief Human Resources Officer) | Open-market sale | 3,469 | $12.83 | $44.5K | Form 4 |
Ask the chat about SGRY's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: SURGERY PARTNERS INC (SGRY).
Last updated 2026-08-18 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.